Journal article icon

Journal article

Generalised urticaria and angioedema complicating switch back from subcutaneous to intravenous vedolizumab therapy

Abstract:
We report a unique case of a 34-year-old man with ulcerative colitis, previously in complete remission with intravenous vedolizumab monotherapy, who developed an urticarial injection-site reaction on switching to a subcutaneous preparation and thereafter experienced a new hypersensitivity reaction on switch back to intravenous vedolizumab, necessitating complete discontinuation from this drug. This case highlights the need for vigilance on switching back to intravenous preparations of vedolizumab, in response to injection-site reactions with a subcutaneous preparation, even if the intravenous preparation had been previously well tolerated by the patient.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1136/flgastro-2023-102380

Authors


Publisher:
BMJ Publishing Group
Journal:
Frontline Gastroenterology More from this journal
Volume:
14
Issue:
5
Pages:
432-434
Place of publication:
England
Publication date:
2023-03-27
Acceptance date:
2023-03-17
DOI:
EISSN:
2041-4145
ISSN:
2041-4137
Pmid:
37581188


Language:
English
Pubs id:
1541066
UUID:
uuid_7fb11933-24bd-4fed-b993-aeb8a49ec275
Local pid:
pubs:1541066
Source identifiers:
W4361017980
Deposit date:
2026-01-23
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP